The research centre is located at the Department of Biomedicine at the Haukeland University Hospital campus in Bergen, Norway. The mission of K.G.
The research centre is located at the Department of Biomedicine at the Haukeland University Hospital campus. Jebsen Centre for Neuropsychiatric Disorders (KGJN) is to perform interdisciplinary translational research on neuropsychiatric disorders, with an emphasis on attention-deficit hyperactivity disorder (ADHD) and related neurodevelopmental disorders. The Centre was established in 2011 and we h
ave since collected clinical, brain imaging and genetic data on approximately 2000 Norwegian children and adults with ADHD, as well as control persons. Although many aspects of neuropsychiatric disorders are being intensively investigated at different locations around the world, the interdisciplinary approach of the Centre is unique in Norway. Together with collaborating centres in Europe and the Americas, we have performed clinical studies, brain imaging studies and genome wide genetic analyses. This has recently culminated in identification of the first genome wide significant ADHD susceptibility genes. Data from Norway’s population based registries has provided us with opportunities to study a large number of ADHD patients, and has enabled analyses of other risk factors for, as well as comorbidities with ADHD, analyses that will be elaborated in future studies. The following objectives forms the basis of our research focus:
1. To identify new pathophysiological mechanisms in ADHD and related neuropsychiatric
disorders.
2. To identify new therapeutic targets and treatment strategies for neuropsychiatric disorders.
3. To establish local technology platforms and national and international collaborative
networks needed for continued discovery and innovation in neuropsychiatry.
17/10/2022